{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:55:04Z","timestamp":1781513704879,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Maharshi Dayanand University Rohtak"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05112-3","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:47:10Z","timestamp":1771476430000},"page":"11515-11526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model"],"prefix":"10.1007","volume":"399","author":[{"given":"Nisha","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"12","key":"5112_CR1","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.31557\/APJCP.2022.23.12.4261","volume":"23","author":"AA Abd-Rabou","year":"2022","unstructured":"Abd-Rabou AA, Ahmed HH, Mohamed SH, Kotob SE, Kishta MS (2022) Nanotherapy: new approach for impeding hepatic cancer microenvironment via targeting multiple molecular pathways. Asian Pac J Cancer Prev 23(12):4261","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"5112_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10876-022-02224-7","volume":"34","author":"AA Abd-Rabou","year":"2023","unstructured":"Abd-Rabou AA, Ahmed HH, Kishta MS, Zoheir KM (2023) Selective viramidine-loaded aptamer-nanoparticles trigger cell cycle arrest in nucleolin-expressed hepatoma cells through modulation of CDC25A\/p53\/PI3k pathway. J Cluster Sci 34(1):335\u2013348. https:\/\/doi.org\/10.1007\/s10876-022-02224-7","journal-title":"J Cluster Sci"},{"key":"5112_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03689-1","author":"AA Abd-Rabou","year":"2025","unstructured":"Abd-Rabou AA, Kamal M, Alharbi HY, Aljohani MS, El-Atawy MA, Kishta MS (2025) Modulation of PI3K\/AKT signaling and DFT modeling via selected pharmaceutical compounds attenuates carrageenan-induced inflammation and oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03689-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5112_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.14715\/cmb\/2024.70.1.3","volume":"70","author":"WH Abdulaal","year":"2024","unstructured":"Abdulaal WH, Helmi N, Hamza A, Salem NA (2024) Cerium oxide nanoparticles impact on sepsis-induced cerebral injury: deciphering miRNA\/NF-\u03baB\/TLR signalling pathway. Cell Mol Biol 70(1):19\u201327. https:\/\/doi.org\/10.14715\/cmb\/2024.70.1.3","journal-title":"Cell Mol Biol"},{"key":"5112_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135668","volume":"280","author":"M Adhikari","year":"2024","unstructured":"Adhikari M, Atta OM, Kishta MS, Maboruk M, Shi Z, Yang G (2024) Lysozyme-enhanced cellulose nanofiber, chitosan, and graphene oxide multifunctional nanocomposite for potential burn wound healing applications. Int J Biol Macromol 280:135668. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135668","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5112_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","volume":"18","author":"H Aegerter","year":"2023","unstructured":"Aegerter H, Lambrecht BN (2023) The pathology of asthma: what is obstructing our view? Annu Rev Pathol Mech Dis 18(1):387\u2013409. https:\/\/doi.org\/10.1146\/annurev-pathol-042220-015902","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5112_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2024.102461","volume":"89","author":"HA Aglan","year":"2024","unstructured":"Aglan HA, Ahmed HH, Beherei HH, Abdel-Hady BM, Ekram B, Kishta MS (2024) Generation of cardiomyocytes from stem cells cultured on nanofibrous scaffold: experimental approach for attenuation of myocardial infarction. Tissue Cell 89:102461. https:\/\/doi.org\/10.1016\/j.tice.2024.102461","journal-title":"Tissue Cell"},{"key":"5112_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2023.104083","volume":"314","author":"IAO Alhirmizi","year":"2023","unstructured":"Alhirmizi IAO, Uysal F, Arslan SO, \u00d6z\u00fcnl\u00fc SA\u00c7, Ko\u00e7 A, Parlar A, Bayram KK (2023) Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-\u03baB binding activity. Respir Physiol Neurobiol 314:104083. https:\/\/doi.org\/10.1016\/j.resp.2023.104083","journal-title":"Respir Physiol Neurobiol"},{"issue":"5","key":"5112_CR9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ppul.25263","volume":"56","author":"BA Almomani","year":"2021","unstructured":"Almomani BA, Al\u2010Qawasmeh BS, Al\u2010Shatnawi SF, Awad S, Alzoubi SA (2021) Predictors of proper inhaler technique and asthma control in pediatric patients with asthma. Pediatr Pulmonol 56(5):866\u2013874. https:\/\/doi.org\/10.1002\/ppul.25263","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"5112_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13040677","volume":"13","author":"AR Alsayed","year":"2023","unstructured":"Alsayed AR, Abu-Samak MS, Alkhatib M (2023) Asthma-COPD overlap in clinical practice (ACO_CP 2023): toward precision medicine. J Pers Med 13(4):677. https:\/\/doi.org\/10.3390\/jpm13040677","journal-title":"J Pers Med"},{"key":"5112_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117362","volume":"179","author":"HD Bae","year":"2024","unstructured":"Bae HD, Cho M, Lee K (2024) Therapeutic efficacy of JEW-M449, an anti-TCTP monoclonal antibody, administered via the nasal route in a BALB\/c mouse model of ovalbumin-induced acute asthma. Biomed Pharmacother 179:117362. https:\/\/doi.org\/10.1016\/j.biopha.2024.117362","journal-title":"Biomed Pharmacother"},{"key":"5112_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106906","volume":"88","author":"S Bodkhe","year":"2020","unstructured":"Bodkhe S, Nikam M, Sherje AP, Khan T, Suvarna V, Patel K (2020) Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS. Int Immunopharmacol 88:106906. https:\/\/doi.org\/10.1016\/j.intimp.2020.106906","journal-title":"Int Immunopharmacol"},{"key":"5112_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-4939-8994-2_28","volume-title":"Pre-Clinical Models: Techniques and Protocols","author":"M Casaro","year":"2018","unstructured":"Casaro M, Souza VR, Oliveira FA, Ferreira CM (2018) OVA-induced allergic airway inflammation mouse model. Pre-Clinical Models: Techniques and Protocols. Springer New York, New York, NY, pp 297\u2013301. https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_28"},{"issue":"10","key":"5112_CR14","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00210-021-02117-y","volume":"394","author":"M Cellat","year":"2021","unstructured":"Cellat M, Kuzu M, \u0130\u015fler CT, Etyemez M, Dikmen N, Uyar A, G\u00f6k\u00e7ek \u0130, T\u00fcrk E, G\u00fcven\u00e7 M (2021) Tyrosol improves ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation. Naunyn Schmiedebergs Arch Pharmacol 394(10):2061\u20132075. https:\/\/doi.org\/10.1007\/s00210-021-02117-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5112_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12016-020-08830-5","volume":"62","author":"J Chatkin","year":"2022","unstructured":"Chatkin J, Correa L, Santos U (2022) External environmental pollution as a risk factor for asthma. Clin Rev Allergy Immunol 62(1):72\u201389. https:\/\/doi.org\/10.1007\/s12016-020-08830-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"5112_CR16","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1021\/acs.biomac.2c00576","volume":"23","author":"EF Craparo","year":"2022","unstructured":"Craparo EF, Cabibbo M, Scialabba C, Giammona G, Cavallaro G (2022) Inhalable formulation based on lipid\u2013polymer hybrid nanoparticles for the macrophage targeted delivery of roflumilast. Biomacromol 23(8):3439\u20133451","journal-title":"Biomacromol"},{"issue":"3","key":"5112_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/tox.23049","volume":"36","author":"R Dai","year":"2021","unstructured":"Dai R, Niu M, Wang N, Wang Y (2021) Syringin alleviates ovalbumin\u2010induced lung inflammation in BALB\/c mice asthma model via NF\u2010\u03baB signaling pathway. Environ Toxicol 36(3):433\u2013444. https:\/\/doi.org\/10.1002\/tox.23049","journal-title":"Environ Toxicol"},{"issue":"2","key":"5112_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1513\/AnnalsATS.202204-368OC","volume":"20","author":"AE Dixon","year":"2023","unstructured":"Dixon AE, Que LG, Kalhan R, Dransfield MT, Rogers L, Gerald LB, Wise RA (2023) Roflumilast may increase risk of exacerbations when used to treat poorly controlled asthma in people with obesity. Ann Am Thorac Soc 20(2):206\u2013214. https:\/\/doi.org\/10.1513\/AnnalsATS.202204-368OC","journal-title":"Ann Am Thorac Soc"},{"key":"5112_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155629","volume":"263","author":"T El Sherkawi","year":"2024","unstructured":"El Sherkawi T, Saeid AB, Yeung S, Chellappan DK, Mohamad S, Kokkinis S, Bani Saeid A, Sudhakar S, Singh SK, Gupta G, Paudel KR, Hansbro PM, Oliver B, De Rubis G, Dua K (2024) Therapeutic potential of 18-\u03b2-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD. Pathol Res Pract 263:155629. https:\/\/doi.org\/10.1016\/j.prp.2024.155629","journal-title":"Pathol Res Pract"},{"key":"5112_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155629","volume":"263","author":"T El Sherkawi","year":"2024","unstructured":"El Sherkawi T, Saeid AB, Yeung S, Chellappan DK, Mohamad S, Kokkinis S, Dua K (2024b) Therapeutic potential of 18-\u03b2-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD. Pathol Res Pract 263:155629. https:\/\/doi.org\/10.1016\/j.prp.2024.155629","journal-title":"Pathol Res Pract"},{"key":"5112_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109348","volume":"113","author":"A Elmasry","year":"2022","unstructured":"Elmasry A, Aboukamar WA, Hany H, Elmehankar MS (2022) The immunomodulatory effects of roflumilast on tachyzoite-bradyzoite transition in a murine model of Toxoplasma gondii. Int Immunopharmacol 113:109348. https:\/\/doi.org\/10.1016\/j.intimp.2022.109348","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"5112_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/all.15609","volume":"78","author":"GM Gauvreau","year":"2023","unstructured":"Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, C\u00f4t\u00e9 A, Davis BE, Sehmi R (2023) Sounding the alarmins\u2014the role of alarmin cytokines in asthma. Allergy 78(2):402\u2013417. https:\/\/doi.org\/10.1111\/all.15609","journal-title":"Allergy"},{"issue":"9","key":"5112_CR23","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/resp.14556","volume":"28","author":"PG Gibson","year":"2023","unstructured":"Gibson PG, McDonald VM, Thomas D (2023) Treatable traits, combination inhaler therapy and the future of asthma management. Respirology 28(9):828\u2013840. https:\/\/doi.org\/10.1111\/resp.14556","journal-title":"Respirology"},{"issue":"6","key":"5112_CR24","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1007\/s00210-023-02882-y","volume":"397","author":"N Gulati","year":"2024","unstructured":"Gulati N, Chellappan DK, MacLoughlin R, Gupta G, Singh SK, Oliver BG, Dua K, Dureja H (2024) Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases. Naunyn Schmiedebergs Arch Pharmacol 397(6):3695\u20133707. https:\/\/doi.org\/10.1007\/s00210-023-02882-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5112_CR25","doi-asserted-by":"publisher","unstructured":"Gulati N, Paudel KR, De Rubis G, Dua K, Dureja H (2026) Preparation, Characterization and In-Vitro Efficacy of Roflumilast Nanosuspension in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease. J Pharm Innov 21:178. https:\/\/doi.org\/10.1007\/s12247-026-10402-7","DOI":"10.1007\/s12247-026-10402-7"},{"key":"5112_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107302","author":"T Gulsun","year":"2025","unstructured":"Gulsun T, Demir H, Borna SE, Sahin S (2025) Furosemide nanosuspensions: preparation, characterization and evaluation of the interplay between solubility and permeability. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2025.107302","journal-title":"J Drug Deliv Sci Technol"},{"key":"5112_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/0126661454405390251015163802","author":"J Gupta","year":"2025","unstructured":"Gupta J, Sultana S, Sharma V (2025) Advancements in nanotechnology for targeted drug delivery in chronic obstructive pulmonary disease. Curr Mater Sci. https:\/\/doi.org\/10.2174\/0126661454405390251015163802","journal-title":"Curr Mater Sci"},{"issue":"1","key":"5112_CR28","doi-asserted-by":"publisher","DOI":"10.15326\/jcopdf.2024.0559","volume":"12","author":"NA Hanania","year":"2025","unstructured":"Hanania NA, Celli BR (2025) Phosphodiesterase inhibition as a therapeutic strategy for chronic obstructive pulmonary disease: where we have been and what lies ahead. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 12(1):82. https:\/\/doi.org\/10.15326\/jcopdf.2024.0559","journal-title":"Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation"},{"key":"5112_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109485","volume":"123","author":"WC Huang","year":"2024","unstructured":"Huang WC, Wu SJ, Yeh KW, Huang TH, Liou CJ (2024) Protective effects of myricetin on airway inflammation and oxidative stress in ovalbumin-induced asthma mice. J Nutr Biochem 123:109485. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109485","journal-title":"J Nutr Biochem"},{"issue":"5","key":"5112_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050384","volume":"13","author":"M Hussain","year":"2024","unstructured":"Hussain M, Liu G (2024) Eosinophilic asthma: pathophysiology and therapeutic horizons. Cells 13(5):384. https:\/\/doi.org\/10.3390\/cells13050384","journal-title":"Cells"},{"issue":"17","key":"5112_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/foods13172713","volume":"13","author":"S Ishii","year":"2024","unstructured":"Ishii S, Koga Y, Yokooji T, Kakino M, Ogino R, Taogoshi T, Matsuo H (2024) Evaluation of a novel detection method for allergen-specific IgE antibodies with IgE receptor crosslinking using rat food allergy model. Foods 13(17):2713. https:\/\/doi.org\/10.3390\/foods13172713","journal-title":"Foods"},{"key":"5112_CR32","doi-asserted-by":"publisher","unstructured":"Ismail, M. F., ElMeshad, A. N., & Salem, N. A. H. (2013). Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer\u2019s disease. International journal of nanomedicine, 393\u2013406. https:\/\/doi.org\/10.2147\/IJN.S39232","DOI":"10.2147\/IJN.S39232"},{"issue":"1","key":"5112_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010136","volume":"17","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Boddu SH, Attimarad M, Nair AB (2025) Nanosuspension innovations: expanding horizons in drug delivery techniques. Pharmaceutics 17(1):136. https:\/\/doi.org\/10.3390\/pharmaceutics17010136","journal-title":"Pharmaceutics"},{"issue":"1","key":"5112_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9110798","volume":"2022","author":"SV Jasemi","year":"2022","unstructured":"Jasemi SV, Khazaei H, Fakhri S, Mohammadi-Noori E, Farzaei MH (2022) Naringenin improves ovalbumin\u2010induced allergic asthma in rats through antioxidant and anti\u2010inflammatory effects. Evid Based Complement Alternat Med 2022(1):9110798. https:\/\/doi.org\/10.1155\/2022\/9110798","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"5112_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9110798","volume":"2022","author":"SV Jasemi","year":"2022","unstructured":"Jasemi SV, Khazaei H, Fakhri S, Mohammadi-Noori E, Farzaei MH (2022) Naringenin improves ovalbumin\u2010induced allergic asthma in rats through antioxidant and anti\u2010inflammatory effects. Evid Based Complement Alternat Med 2022(1):9110798. https:\/\/doi.org\/10.1155\/2022\/9110798","journal-title":"Evid Based Complement Alternat Med"},{"key":"5112_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102052","volume":"70","author":"J Kawagoe","year":"2021","unstructured":"Kawagoe J, Maeda Y, Kikuchi R, Takahashi M, Fuchikami JI, Tsuji T, Aoshiba K (2021) Differential effects of dexamethasone and roflumilast on asthma in mice with or without short cigarette smoke exposure. Pulm Pharmacol Ther 70:102052. https:\/\/doi.org\/10.1016\/j.pupt.2021.102052","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"5112_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/cea.12670","volume":"46","author":"SW Kim","year":"2016","unstructured":"Kim SW, Kim JH, Park CK, Kim TJ, Lee SY, Kim YK, Kwon SS, Rhee CK, Yoon HK (2016) Effect of roflumilast on airway remodelling in a murine model of chronic asthma. Clin Exp Allergy 46(5):754\u2013763. https:\/\/doi.org\/10.1111\/cea.12670","journal-title":"Clin Exp Allergy"},{"key":"5112_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112082","volume":"253","author":"TM Kim","year":"2020","unstructured":"Kim TM, Paudel KR, Kim DW (2020) Eriobotrya japonica leaf extract attenuates airway inflammation in ovalbumin-induced mice model of asthma. J Ethnopharmacol 253:112082. https:\/\/doi.org\/10.1016\/j.jep.2019.112082","journal-title":"J Ethnopharmacol"},{"key":"5112_CR39","doi-asserted-by":"publisher","unstructured":"Lee D, Kong B, Kwak G, Kang B, Swaby C, Fanaroff R, ... & Suk JS (2025) Clinically translatable anti-fibrotic nanosuspension for inhaled treatment of idiopathic pulmonary fibrosis. Drug Deliv Transl Res\u00a01\u201311. https:\/\/doi.org\/10.1007\/s13346-025-01973-y","DOI":"10.1007\/s13346-025-01973-y"},{"issue":"1","key":"5112_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06455-6","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Xu Y, Yan M, Yu Y, Guo Y (2022) 18\u03b2-glycyrrhetinic acid suppresses allergic airway inflammation through NF-\u03baB and Nrf2\/HO-1 signaling pathways in asthma mice. Sci Rep 12(1):3121. https:\/\/doi.org\/10.1038\/s41598-022-06455-6","journal-title":"Sci Rep"},{"issue":"6","key":"5112_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060803","volume":"17","author":"ZK Maded","year":"2024","unstructured":"Maded ZK, Sfar S, Taqa GAA, Lassoued MA, Ben Hadj Ayed O, Fawzi HA (2024) Development and optimization of dipyridamole-and roflumilast-loaded nanoemulsion and nanoemulgel for enhanced skin permeation: formulation, characterization, and in vitro assessment. Pharmaceuticals (Basel) 17(6):803. https:\/\/doi.org\/10.3390\/ph17060803","journal-title":"Pharmaceuticals (Basel)"},{"key":"5112_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejps.2018.06.015","volume":"122","author":"AA Mahmoud","year":"2018","unstructured":"Mahmoud AA, Elkasabgy NA, Abdelkhalek AA (2018) Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast. Eur J Pharm Sci 122:64\u201376. https:\/\/doi.org\/10.1016\/j.ejps.2018.06.015","journal-title":"Eur J Pharm Sci"},{"key":"5112_CR43","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S242961","author":"MG Matera","year":"2021","unstructured":"Matera MG, Ora J, Cavalli F, Rogliani P, Cazzola M (2021) New avenues for phosphodiesterase inhibitors in asthma. J Exp Pharmacol. https:\/\/doi.org\/10.2147\/JEP.S242961","journal-title":"J Exp Pharmacol"},{"key":"5112_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-023-05784-5","volume":"25","author":"Y Mehmood","year":"2023","unstructured":"Mehmood Y, Shahid H, Tahir MA (2023) Remdesivir nanosuspension for potential nasal drug delivery: determination of pro-inflammatory interleukin IL-4 mRNA expression and industrial scale-up strategy. J Nanopart Res 25:129. https:\/\/doi.org\/10.1007\/s11051-023-05784-5","journal-title":"J Nanopart Res"},{"key":"5112_CR45","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S410036","author":"I Mommers","year":"2023","unstructured":"Mommers I, Van Boven JF, Schuiling-Veninga CC, Bos JH, Koetsier M, Hak E, Bijlsma MJ (2023) Real-world dispensing patterns of inhalation medication in young adult asthma: an inception cohort study. Clin Epidemiol. https:\/\/doi.org\/10.2147\/CLEP.S410036","journal-title":"Clin Epidemiol"},{"issue":"5","key":"5112_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/1535370216685006","volume":"242","author":"HA Murad","year":"2017","unstructured":"Murad HA, Habib HS, Rafeeq MM, Sulaiman MI, Abdulrahman AS, Khabaz MN (2017) Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. Exp Biol Med (Maywood) 242(5):516\u2013526. https:\/\/doi.org\/10.1177\/1535370216685006","journal-title":"Exp Biol Med (Maywood)"},{"issue":"9","key":"5112_CR47","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00210-012-0772-9","volume":"385","author":"MA Nader","year":"2012","unstructured":"Nader MA, El-Awady MS, Shalaby AA, El-Agamy DS (2012) Sitagliptin exerts anti-inflammatory and anti-allergic effects in ovalbumin-induced murine model of allergic airway disease. Naunyn Schmiedebergs Arch Pharmacol 385(9):909\u2013919. https:\/\/doi.org\/10.1007\/s00210-012-0772-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"5112_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/sinusitis5010003","volume":"5","author":"P Nair","year":"2021","unstructured":"Nair P, Prabhavalkar K (2021) Anti-asthmatic effects of saffron extract and salbutamol in an ovalbumin-induced airway model of allergic asthma. Sinusitis 5(1):17\u201331. https:\/\/doi.org\/10.3390\/sinusitis5010003","journal-title":"Sinusitis"},{"issue":"4","key":"5112_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2125.2009.03478.x","volume":"68","author":"N Nassr","year":"2009","unstructured":"Nassr N, Huennemeyer A, Herzog R, Von Richter O, Hermann R, Koch M, Duffy K, Zech K, Lahu G (2009) Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N\u2010oxide in healthy subjects. Br J Clin Pharmacol 68(4):580\u2013587. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03478.x","journal-title":"Br J Clin Pharmacol"},{"key":"5112_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152284","author":"R Noor","year":"2025","unstructured":"Noor R, Naz S, Khan JZ, Mazhar MU, Ilyas Z, Tanveer O, Tipu MK (2025) Santonin attenuates ovalbumin-induced airway inflammation by inhibiting IL-4\/IL-13 signaling. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152284","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5112_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1165\/rcmb.2015-0345OC","volume":"55","author":"HJ Park","year":"2016","unstructured":"Park HJ, Lee JH, Park YH, Han H, Sim DW, Park KH, Park JW (2016) Roflumilast ameliorates airway hyperresponsiveness caused by diet-induced obesity in a murine model. Am J Respir Cell Mol Biol 55(1):82\u201391. https:\/\/doi.org\/10.1165\/rcmb.2015-0345OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"5112_CR52","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/1440-1681.13635S","volume":"49","author":"CK Park","year":"2022","unstructured":"Park CK, An TJ, Kim JH, Rhee CK, Yoon HK (2022) Synergistic effect of roflumilast with dexamethasone in a neutrophilic asthma mouse model. Clin Exp Pharmacol Physiol 49(6):624\u2013632. https:\/\/doi.org\/10.1111\/1440-1681.13635S","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5112_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-021-01742-w","volume":"21","author":"R Rashmi","year":"2021","unstructured":"Rashmi R, Kumar P, Srivastava S, Muhammad T (2021) Understanding socio-economic inequalities in the prevalence of asthma in India: an evidence from national sample survey 2017\u201318. BMC Pulm Med 21:1\u201312","journal-title":"BMC Pulm Med"},{"issue":"1","key":"5112_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03730-w","volume":"25","author":"K Sakurai","year":"2025","unstructured":"Sakurai K, Nakayama S, Chubachi S, Otake S, Shimada T, Irie H, Fukunaga K (2025) Roflumilast reduces the number of lung adenocarcinomas, inflammation, and emphysema in a smoking-induced mouse model. BMC Pulm Med 25(1):262. https:\/\/doi.org\/10.1186\/s12890-025-03730-w","journal-title":"BMC Pulm Med"},{"issue":"5","key":"5112_CR55","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.tice.2016.06.005","volume":"48","author":"NA Salem","year":"2016","unstructured":"Salem NA, Ahmed HH, Aglan HA, ElShebiney SA (2016) Nanofiber-expanded stem cells mitigate liver fibrosis: experimental study. Tissue Cell 48(5):544\u2013551. https:\/\/doi.org\/10.1016\/j.tice.2016.06.005","journal-title":"Tissue Cell"},{"key":"5112_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140516","volume":"302","author":"NA Salem","year":"2025","unstructured":"Salem NA, ElShebiney SA, Mabrouk M, Kishta MS, Galal AF, Osama L, Beherei HH (2025) Enhanced bone regeneration using mesenchymal stem cell-loaded 3D-printed alginate-calcium titanate scaffolds: a calvarial defect model study. Int J Biol Macromol 302:140516. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140516","journal-title":"Int J Biol Macromol"},{"issue":"22","key":"5112_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216042","volume":"24","author":"IA Savin","year":"2023","unstructured":"Savin IA, Zenkova MA, Sen\u2019kova AV (2023) Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process. Int J Mol Sci 24(22):16042. https:\/\/doi.org\/10.3390\/ijms242216042","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5112_CR58","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41576-024-00695-0","volume":"25","author":"I Sayers","year":"2024","unstructured":"Sayers I, John C, Chen J, Hall IP (2024) Genetics of chronic respiratory disease. Nat Rev Genet 25(8):534\u2013547. https:\/\/doi.org\/10.1038\/s41576-024-00695-0","journal-title":"Nat Rev Genet"},{"key":"5112_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119771","volume":"588","author":"EY Suzuki","year":"2020","unstructured":"Suzuki EY, Simon A, da Silva AL, Amaro MI, de Almeida GS, Agra LC, Cabral LM, Rocco PRM, Healy AM, de Sousa VP (2020) Effects of a novel roflumilast and formoterol fumarate dry powder inhaler formulation in experimental allergic asthma. Int J Pharm 588:119771. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119771","journal-title":"Int J Pharm"},{"key":"5112_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102198","volume":"79","author":"Y Takeda","year":"2023","unstructured":"Takeda Y, Takahashi M, Fuchikami JI, Nakamura H, Aoshiba K (2023) Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: comparison with the effect of dexamethasone. Pulm Pharmacol Ther 79:102198. https:\/\/doi.org\/10.1016\/j.pupt.2023.102198","journal-title":"Pulm Pharmacol Ther"},{"key":"5112_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jddst.2019.04.024","volume":"52","author":"E Tashan","year":"2019","unstructured":"Tashan E, Karakucuk A, Celebi N (2019) Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach. J Drug Deliv Sci Technol 52:37\u201345. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.024","journal-title":"J Drug Deliv Sci Technol"},{"key":"5112_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02864","author":"VR Thakur","year":"2019","unstructured":"Thakur VR, Khuman V, Beladiya JV, Chaudagar KK, Mehta AA (2019) An experimental model of asthma in rats using ovalbumin and lipopolysaccharide allergens. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02864","journal-title":"Heliyon"},{"key":"5112_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biopha.2017.10.073","volume":"97","author":"CL Venturini","year":"2018","unstructured":"Venturini CL, Macho A, Arunachalam K, de Almeida DAT, Rosa SIG, Pavan E, Balogun SO, Damazo AS, Martins D, de Oliveira Martins DT (2018) Vitexin inhibits inflammation in murine ovalbumin-induced allergic asthma. Biomed Pharmacother 97:143\u2013151. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.073","journal-title":"Biomed Pharmacother"},{"key":"5112_CR64","doi-asserted-by":"publisher","unstructured":"Wedzicha JA, Calverley PM, & Rabe KF (2016) Roflumilast: a review of its use in the treatment of COPD. Int j chronic obstructive pulm dis 81\u201390. https:\/\/doi.org\/10.2147\/COPD.S89849","DOI":"10.2147\/COPD.S89849"},{"key":"5112_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110264","volume":"119","author":"K W\u00f3jcik-Pszczo\u0142a","year":"2023","unstructured":"W\u00f3jcik-Pszczo\u0142a K, Pociecha K, Ch\u0142o\u0144-Rzepa G, Zadro\u017cna M, Nowak B, Plutecka H, Koczurkiewicz-Adamczyk P, Przejczowska-Pomierny K, P\u0119kala E, Gosens R, Wyska E (2023) Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma. Int Immunopharmacol 119:110264. https:\/\/doi.org\/10.1016\/j.intimp.2023.110264","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5112_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06777-5","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Wang P, Xie X, Yang X, Tang S, Zhao J, Feng X (2024) Gasdermin D silencing alleviates airway inflammation and remodeling in an ovalbumin-induced asthmatic mouse model. Cell Death Dis 15(6):400. https:\/\/doi.org\/10.1038\/s41419-024-06777-5","journal-title":"Cell Death Dis"},{"issue":"8","key":"5112_CR67","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s10096-021-04183-9","volume":"40","author":"W Yang","year":"2021","unstructured":"Yang W, Dong Z, Li Y, Zhang Y, Fu H, Xie Y (2021) Therapeutic efficacy of chitosan nanoparticles loaded with BCG-polysaccharide nucleic acid and ovalbumin on airway inflammation in asthmatic mice. Eur J Clin Microbiol Infect Dis 40(8):1623\u20131631. https:\/\/doi.org\/10.1007\/s10096-021-04183-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"5112_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123789","volume":"27","author":"Z Yang","year":"2022","unstructured":"Yang Z, Li X, Fu R, Hu M, Wei Y, Hu X, Huang F (2022) Therapeutic effect of Renifolin F on airway allergy in an ovalbumin-induced asthma mouse model in vivo. Molecules 27(12):3789. https:\/\/doi.org\/10.3390\/molecules27123789","journal-title":"Molecules"},{"key":"5112_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102531","volume":"37","author":"CH Yang","year":"2024","unstructured":"Yang CH, Lv JJ, Li XY, Yang XT, Yin MY (2024) Global burden of asthma in young adults in 204 countries and territories, 1990\u20132019: systematic analysis of the Global burden of disease study 2019. Prev Med Rep 37:102531. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102531","journal-title":"Prev Med Rep"},{"key":"5112_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.etap.2018.09.004","volume":"64","author":"H Yosri","year":"2018","unstructured":"Yosri H, Said E, Elkashef WF, Gameil NM (2018) Modulatory role of gabapentin against ovalbumin-induced asthma, bronchial and airway inflammation in mice. Environ Toxicol Pharmacol 64:18\u201325. https:\/\/doi.org\/10.1016\/j.etap.2018.09.004","journal-title":"Environ Toxicol Pharmacol"},{"key":"5112_CR71","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S165161","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, Luo P (2018) Pharmacological mechanism of roflumilast in the treatment of asthma\u2013COPD overlap. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S165161","journal-title":"Drug Des Devel Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05112-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05112-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05112-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:19:23Z","timestamp":1781511563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05112-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05112-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed after approval from the institution animal ethics committee (IAEC) with Establishment Reg. No. 1767 GO\/RE\/S\/14\/CPCSEA for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) vide letter no CAH\/2024\/55\u201361 dated 26\u201304-2025.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}